Cardiac surgeons’ practices and attitudes toward addiction care for patients with substance use disorders

References

• Centers for Disease Control and Prevention. Increases in heroin overdose deaths — 28 States, 2010 to 2012. Morb Mortalitiy Wkly Rep. 2014;63(39):849–854.
   PubMed Web of Science ®Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382.
   PubMed Web of Science ®Google Scholar
• Horner G, Daddona J, Burke DJ, Cullinane J, Skeer M, Wurcel AG. “You’re kind of at war with yourself as a nurse”: perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder. PLoS One. 2019;14(10):e0224335.
   PubMed Web of Science ®Google Scholar
• Coye AE, Tookes HE, Li H, et al. Hospital costs of injection drug use in Florida. Clin Infect Dis. 2021;42(3):499–502.
   Google Scholar
• Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood). 2016;35(5):832–837.
   PubMed Web of Science ®Google Scholar
• Hsu DJ, McCarthy EP, Stevens JP, Mukamal KJ. Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12. Addiction. 2017;112(9):1558–1564.
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Alqahtani F, Alhajji M, Berzingi CO, Sohail MR. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. Mayo Clin Proc. 2020;95(5):858–866.
   Web of Science ®Google Scholar
• Wurcel AG, Anderson JE, Chui KKH, et al. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3):ofw157.
   PubMed Web of Science ®Google Scholar
• Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: A retrospective cohort study. BMC Infect Dis. 2018;18(1):532.
   PubMedGoogle Scholar
• Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med. 2019;170(1):31–40.
   PubMed Web of Science ®Google Scholar
• Geirsson A, Schranz A, Jawitz O, et al. The evolving burden of drug use associated infective endocarditis in the United States. Ann Thorac Surg. 2020;110:1185–1192.
   PubMed Web of Science ®Google Scholar
• Nguemeni Tiako MJ, Mori M, Bin Mahmood SU, et al. Recidivism is the leading cause of death among intravenous drug users who underwent cardiac surgery for infective endocarditis. Semin Thorac Cardiovasc Surg. 2019;31(1):40–45.
   PubMed Web of Science ®Google Scholar
• Goodman-Meza D, Weiss RE, Gamboa S, et al. Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):918.
   PubMed Web of Science ®Google Scholar
• Elbatarny M, Bahji A, Bisleri G, Hamilton A. Management of endocarditis among persons who inject drugs: a narrative review of surgical and psychiatric approaches and controversies. Gen Hosp Psychiatry. 2019;57:44–49.
   PubMed Web of Science ®Google Scholar
• Nguemeni Tiako M, Hong S, Bin Mahmood S, et al. Inconsistent addiction treatment for patients undergoing cardiac surgery for injection drug use-associated infective endocarditis. J Addict Med. 2020;14(6):e350–e354. PMID: 32732685.
   PubMed Web of Science ®Google Scholar
• Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8(6):630–644.
   PubMed Web of Science ®Google Scholar
• Bearnot B, Mitton JA, Hayden M, Park ER. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: results from a qualitative study. J Subst Abuse Treat. 2019;102:16–22.
   PubMed Web of Science ®Google Scholar
• Simmonds L, Coomber R. Injecting drug users: a stigmatised and stigmatising population. Int J Drug Policy. 2009;20(2):121–130.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Rich JD. Barriers to post-acute care for patients on opioid agonist therapy; an example of systematic stigmatization of addiction. J Gen Intern Med. 2017;32(1):17–19.
   PubMed Web of Science ®Google Scholar
• Allespach H, Stahl KD. “Dread to treat” patients in cardiac surgery: global strategies for interacting with cardiothoracic patients with substance use disorders. J Card Surg. 2019;34(12):1427–1429.
   PubMed Web of Science ®Google Scholar
• Berk J, Rogers KM, Wilson DJ, Thakrar A, Feldman L. Missed opportunities for treatment of opioid use disorder in the hospital setting: updating an outdated policy. J Hosp Med. 2020;15(10):619–621. (2019-12-18 ONLINE FIRST).
   PubMed Web of Science ®Google Scholar
• Muzyk A, Smothers ZPW, Akrobetu D, et al. Substance use disorder education in medical schools: a scoping review. Acad Med. 2019;94(11):1825–1834.
   PubMed Web of Science ®Google Scholar
• Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services – linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5.
   PubMed Web of Science ®Google Scholar
• Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796–2803.
   PubMed Web of Science ®Google Scholar
• Tyerman Z, Shah S, Mehaffey JH, et al. Cost-effectiveness of postoperative drug rehabilitation for injection drug users. Ann Thorac Surg. 2019;110(2):492–499.
   Web of Science ®Google Scholar
• Priest KC, McCarty D. Making the business case for an addiction medicine consult service: a qualitative analysis. BMC Health Serv Res. 2019;19(1):822.
   PubMed Web of Science ®Google Scholar
• Nguemeni Tiako MJ, Mori M, Geirsson A. Nuanced approach to surgical tricuspid valve endocarditis. Ann Thorac Surg. 2019;107(1):322–323.
   PubMed Web of Science ®Google Scholar
• Hayden M, Moore A. Attitudes and approaches towards repeat valve surgery in recurrent injection drug use-associated infective endocarditis: a qualitative study. J Addict Med. 2019;14(3):217–223.
   Web of Science ®Google Scholar
• Search for Surgeons | CTSNet. https://www.ctsnet.org/surgeons. Accessed April 20, 2020.
   Google Scholar
• Wakeman SE, Kanter GP, Donelan K. Institutional substance use disorder intervention improves general internist preparedness, attitudes, and clinical practice. J Addict Med. 2017;11(4):308–314.
   PubMed Web of Science ®Google Scholar
• Vlahakes GJ. “Consensus guidelines for the surgical treatment of infective endocarditis”: the surgeon must lead the team. J Thorac Cardiovasc Surg. 2017;153(6):1259–1260.
   PubMed Web of Science ®Google Scholar
• Erba PA, Habib G, Glaudemans AWJM, Miro JM, Slart RHJA. The round table approach in infective endocarditis & cardiovascular implantable electronic devices infections: make your e-Team come true. Eur J Nucl Med Mol Imaging. 2017;44(7):1107–1108.
   PubMed Web of Science ®Google Scholar
• Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O’Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: a survey of hospitalist physicians. Subst Abus. 2020;1–9.
   PubMed Web of Science ®Google Scholar
• Buchanan NE, Lennox RB, Whitlock R, Belley-Cote E, O’Shea T. Making the cut: perspectives on the surgical management of infective endocarditis among people who use intravenous drugs. Can J Cardiol. 2019;35(10):1416–1418.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Robinson D, Mosquera M, et al. Impact of medications for opioid use disorder on discharge against medical advice among people who inject drugs hospitalized for infective endocarditis. Am J Addict. 2020;29(2):155–159.
   PubMed Web of Science ®Google Scholar
• Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481–485.
   PubMed Web of Science ®Google Scholar
• Nguemeni Tiako MJ, Mszar R, Brooks C 2nd, Mahmood SUB, Mori M, Geirsson A, et al. Cardiac surgeons' treatment approaches for infective endocarditis based on patients’ substance use history. Semin Thorac Cardiovasc Surg. 2020:S1043-0679(20)30426-3.
   Google Scholar
• Protos AN, Trivedi JR, Whited WM, et al. Valvectomy versus replacement for the surgical treatment of tricuspid endocarditis. Ann Thorac Surgery. 2018;04(51):664–669.
   Google Scholar
• Hussain ST, Gordon SM, Streem DW, Blackstone EH, Pettersson GB. Contract with the patient with injection drug use and infective endocarditis: surgeons perspective. J Thorac Cardiovasc Surg. 2017;154(6):2002–2003.
   PubMed Web of Science ®Google Scholar
• Wurcel AG, Yu S, Pacheco M, Warner K. Contracts with people who inject drugs following valve surgery: unrealistic and misguided expectations. J Thorac Cardiovasc Surg. 2017;154(6):2002.
   PubMed Web of Science ®Google Scholar